Description
Manufacturer:
Mankind Pharma Ltd
Salt Composition:
Sitagliptin + Metformin Hydrochloride
Description:
Dynaglipt M Tab is a combination oral antidiabetic medication used to lower blood sugar levels in adults with type 2 diabetes. It contains two active ingredients with complementary mechanisms of action: sitagliptin and metformin hydrochloride.
Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that works by increasing the levels of incretin hormones, which stimulate insulin release and decrease glucagon secretion. Metformin hydrochloride is a biguanide that reduces glucose production in the liver and improves insulin sensitivity.
Dynaglipt M is usually taken once or twice daily with meals. Common side effects may include gastrointestinal disturbances (nausea, diarrhea, abdominal discomfort) and headache. The risk of hypoglycemia is generally low when this combination is used without other medications that can lower blood sugar.
Reviews
There are no reviews yet.